---
title: "002365.SZ (002365.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002365.SZ/news.md"
symbol: "002365.SZ"
name: "002365.SZ"
parent: "https://longbridge.com/en/quote/002365.SZ.md"
datetime: "2026-03-03T17:54:50.328Z"
locales:
  - [en](https://longbridge.com/en/quote/002365.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002365.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002365.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002365.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002365.SZ/news.md)


# 002365.SZ (002365.SZ) — Related News

### [YONGAN PHARMACEUTICAL: The merger of the equity investee Huanggang Daily Chemical into its wholly-owned subsidiary has been completed](https://longbridge.com/en/news/277344395.md)
*2026-03-01T08:16:11.000Z*
> YONGAN PHARMACEUTICAL announced that in November 2025, the company reviewed and approved the proposal for its equity inv

### [An Cheng Sheng's Bubble Dragon new drug clinical phase II/III trial has obtained interim analysis, with safety assured and continuing as planned](https://longbridge.com/en/news/274917197.md)
*2026-02-05T05:15:02.000Z*
> An Cheng Biotechnology (6610-TW) announced that the interim analysis of its new drug AC-203 for the rare disease EBS has

### [YONGAN PHARMACEUTICAL: Net profit is expected to decrease by 56.21%-70.56% in 2025](https://longbridge.com/en/news/274116438.md)
*2026-01-29T08:31:17.000Z*
> YONGAN PHARMACEUTICAL expects its net profit to decline by 56.21%-70.56% in 2025, with the net profit attributable to sh

### [YONGAN PHARMACEUTICAL: Plans to absorb and merge its wholly-owned subsidiary Ling'an Technology](https://longbridge.com/en/news/273668493.md)
*2026-01-26T08:01:57.000Z*
> YONGAN PHARMACEUTICAL announced that it will review the absorption and merger of its wholly-owned subsidiary Ling'an Tec

### [YONGAN PHARMACEUTICAL's investee company Huanggang Daily Chemical is proposed to be absorbed and merged by its wholly-owned subsidiary Tianan Daily Chemical](https://longbridge.com/en/news/265284849.md)
*2025-11-11T07:54:03.000Z*
> YONGAN PHARMACEUTICAL announced that its associate company Huanggang Daily Chemical will be absorbed and merged by its w

### [YONGAN PHARMACEUTICAL's certain directors and senior executives plan to reduce their holdings by no more than 235,400 shares](https://longbridge.com/en/news/264868393.md)
*2025-11-07T12:28:04.000Z*
> YONGAN PHARMACEUTICAL announced that some directors and senior executives plan to reduce their holdings by no more than 

### [YONGAN PHARMACEUTICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 25.4963 million yuan, a year-on-year decrease of 58.78%](https://longbridge.com/en/news/263263886.md)
*2025-10-29T10:37:02.000Z*
> According to the Zhitong Finance APP, YONGAN PHARMACEUTICAL released its third-quarter report for 2025. In the first thr